The 12th IMPACCT Real World Evidence Summit is set to take place October 29–31 in Boston. Featured speaker Kelly H. Zou, who serves as head of global medical analytics, real world evidence, and health economics and outcomes research at Viatris, tells us a little about what participants can expect.
RWD
Panel Provides Insights on Real-World Evidence in Health Care
Real-world data (RWD) can come from a variety of sources, including claims, electronic health records, biobanks, genomics tests, and imaging modalities. Increasingly, it is coming from digital data through electronic health and mobile health modalities. Recent events have pushed innovation in the use of RWD to maximize the value of real-world evidence in an era of big data, data science, and artificial intelligence.
NISS-Merck-HPSS Meet-Up Focuses on RWD
RWD and its applications in the pharmaceutical industry was the topic of the fourth virtual meet-up sponsored by the National Institute of Statistical Sciences and Merck and co-sponsored by the ASA’s Health Policy Statistics Section for the first time this year. Big data, real-world data, and observational data have become ubiquitous and essential components of the drug development and commercialization process.